Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2399-2403

  Reaven, Gerald M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN; THIAZIDE DIURETIC AGENT;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0038306907     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030087     Document Type: Review

References (37)

1. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR 1966 Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1:1136-1137
2. Lucas CP, Estigarribia JA, Darga LL, Reaven GM 1985 Insulin and blood pressure in obesity. Hypertension 7:702-706
3. Modan M, Halkin H, Almog S, Lusky A, Eshkil A, Shefi M, Shitrit A, Fuchs A 1985 Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817
4. Ferrannini E, Buzzigoli G, Bonadona R 1987 Insulin resistance in essential hypertension. N Engl J Med 317:350-357
5. Shen D-C, Shieh S-M, Fuh M, Wu D-A, Chen Y-DI, Reaven GM 1988 Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66:580-583
6. Swislocki ALM, Hoffman BB, Reaven GM 1989 Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 2:419-423
7. Pollare T, Lithell H, Berne C 1990 Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39:167-174
8. Mbanya J-C, Wilkinson R, Thomas T, Alberti K, Taylor R 1988 Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet I:733-734
9. Collins VR, Dowse GK, Finch CF, Zimmet PZ 1990 An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol 43:1369-1378
10. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Havard VV, Bogardus C 1991 Racial differences in the relation between blood pressure and insulin resistance N Engl J Med 324:733-739
11. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H, for the European Group for the Study of Insulin Resistance (EGIR) 1992 insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension 30:1144-1149
12. Marigliano A, Tedde R, Sechi LA, Para A, Pisanu G, Pacifico A 1990 Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am J Hypertens 3:521-526
13. Shamiss A, Carroll J, Rosenthall T 1992 insulin resistance in secondary hypertension. Am J Hypertens 5:26-28
14. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G 1991 Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent. Am J Med 91:589-596
15. Facchini F, Chen Y-DI, Clinkingbeard C, Jeppesen J, Reaven GM 1992 Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5:694-699
16. Allemann Y, Horber FF, Colombo M, Ferrari P, Shaw S, Jaeger P, Weidman P 1993 Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 341:327-331
17. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T 1993 Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensive: possible role of disturbed calcium metabolism. J Hypertens 11:421-426
18. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM 1993 Insulin resistance in offspring of hypertensive parents. BMJ 307:92-96
19. Skarfors ET, Lithell HO, Selinus I 1991 Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 9:217-223
20. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H 1992 Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20:797-801
21. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Akerblom HK 1996 Insulin and blood pressure among healthy children. Am J Hypertens 9:193-199
22. Raitakari OT, Porkka KVK, Rönnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JSA 1995 The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. Diabetologia 38:1042-1050
23. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, Delsignore R., Reaven GM 1994 Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The Barilla factory revisited. Metabolism 48:989-994
24. Meigs JB 2000 Invited commentary: insulin resistance syndrome? Syndrome X? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152:908-911
25. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM 2000 Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 23:171-175
26. Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM 1992 Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 231:235-240
27. Collins R, Peto R, MacMahon S, Herber P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH 1990 Blood pressure, stroke and coronary heart disease. Pt 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335:827-838
28. Reaven GM 1991 Relationship between insulin resistance and hypertension. Diabetes Care 14:33-38
29. Sheuh WH-H, Jeng C-Y, Shieh S-M, Fuh MM, Shen DD, Chen Y-DI, Reaven GM 1992 Insulin resistance and abnormal electrocardiograms in patients with high blood pressure Am J Hypertens 5:444-448
30. Jeppesen J, Hein HO, Suadicani P, Gynelberg F 2000 High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease. Hypertension 36:226-239
31. Jeppesen J, Hein HO, Suadicani P, Gynterberg F 2001 Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Int Med 361-366
32. Reaven GM 1993 Treatment of hypertension; focus on prevention of coronary heart disease. J Clin Endocrinol Metab 76:537-540
33. Reaven GM 2002 Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease: syndrome X. In: Sobell BE, Schneider DJ, eds. Medical management of diabetes and heart disease. New York: Mercel Dekker, Inc.; 117-136
34. Ross R 1986 The pathogenesis of atherosclerosis. N Engl J Med 314:488-500
35. Chen N-G, Abbasi F, Lamendola C, McLaughlin T, Cooke JP, Tsao PS, Reaven GM 1999 Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. Circulation 100:940-943
36. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS 2002 Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-1426
37. Vallance P 2001 Importance of asymmetrical dimethylarginine in cardiovas-cular risk. Lancet 358:2096-2097